Bradley Sorenson

Bradley Sorenson has been involved in the biotechnology industry since 2015, when they were appointed President & CEO of Providence Therapeutics. Bradley then went on to become Co-founder of Arcturus Therapeutics.

Bradley Sorenson has attended the University of Chicago (UofC).